Core Viewpoint - Promino Nutritional Sciences Inc. plans to conduct a non-brokered private placement to raise up to $1,200,000 through the issuance of 40,000,000 units at a price of $0.03 per unit, with each unit consisting of one common share and one half of a common share purchase warrant [1][2]. Group 1: Offering Details - The offering will consist of units priced at $0.03 each, with each unit including one common share and one half of a warrant, where each whole warrant can purchase an additional share at $0.06 for twelve months [1]. - The expected closing date for the offering is around April 15, 2026, subject to regulatory approvals and execution of subscription agreements [3]. - All securities issued will have a resale restriction of four months and one day as per Canadian securities laws [3]. Group 2: Use of Proceeds - The net proceeds from the offering will be allocated to inventory production and general corporate purposes, excluding salaries for officers or directors and payments for investor relations activities [2]. Group 3: Company Overview - Promino Nutritional Sciences is a Canadian company focused on science-based nutrition for muscle health, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [5]. - The company also produces Promino™, which is NSF Certified for Sport® and is endorsed by elite athletes [6].

Core Insights - Promino Nutritional Sciences Inc. announced a significant expansion of its product Rejuvenate Muscle Health™ into an additional 2,105 stores in the U.S., with the rollout scheduled for mid-May 2026 [1] - This expansion will bring the total number of North American distribution points close to 10,000, marking a major milestone for the brand [2] Company and Product Overview - Rejuvenate Muscle Health™ has developed a strong partnership with a major U.S. retailer since its launch in September 2025, focusing on long-term growth and category alignment [3] - The product is positioned within the adult functional beverage category and is formulated with a clinically informed essential amino acid blend aimed at supporting muscle protein synthesis and recovery [5] - The brand has received recognition as the Best Drink by pharmacy, grocery, and e-commerce buyers at a program hosted by ECRM in September 2025, indicating strong market endorsement [4] Market Strategy and Future Plans - The upcoming rollout will be supported by increased production capacity and retail activation initiatives to enhance sell-through rates across the expanded distribution network [5] - Promino is actively pursuing additional retail expansion discussions to further build its presence in the functional beverage and muscle health sectors [6]

Core Viewpoint - Promino Nutritional Sciences Inc. has successfully closed a private placement, raising a total of $1,121,413 by issuing 37,380,433 units at a price of $0.03 per unit, with each unit consisting of one common share and one warrant [1][4] Group 1: Private Placement Details - The private placement involved the issuance of 37,380,433 units at $0.03 per unit, resulting in gross proceeds of $1,121,413 [1] - The company paid finders' fees of $69,233 in cash and issued 2,307,767 finders warrants, each exercisable at $0.06 for twelve months [2] - Upon closing, AlphaNorth Partners Fund Inc. increased its ownership from approximately 8.78% to 10.71%, holding 18,824,851 shares [3] Group 2: Use of Proceeds - Net proceeds from the private placement will be allocated to accelerate growth through inventory investments and for general corporate purposes, excluding salaries for officers or directors [4] Group 3: Company Overview - Promino Nutritional Sciences is focused on science-based nutrition for muscle health, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [5] - The company also produces Promino™, which is NSF Certified for Sport® and endorsed by elite athletes [6]

Core Viewpoint - Promino Nutritional Sciences Inc. is initiating a non-brokered private placement of secured convertible debentures, aiming to raise up to $1 million, with a potential increase to $1.5 million, to support its growth plans for 2026 [1][2]. Group 1: Offering Details - The offering consists of secured convertible debentures with a principal amount of $1,000 each, bearing an interest rate of 15% per annum, payable quarterly [2]. - The conversion price for the debentures is set at the greater of $0.05 or the five-day VWAP of the shares prior to the interest payment date [2]. - The offering is subject to approval from the Canadian Securities Exchange (CSE) and is expected to close around January 30, 2026 [4]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to accelerate growth through inventory investments and for general corporate purposes [3]. Group 3: Additional Securities - The company has granted 500,000 options to purchase shares at an exercise price of $0.05, with a maturity date of December 3, 2028, to a consultant [6]. Group 4: Company Overview - Promino Nutritional Sciences focuses on science-based nutrition for muscle health and recovery, with its core product being Rejuvenate Muscle Health™, a clinically researched amino acid formula [7]. - The company also produces Promino™, which is NSF Certified for Sport® and trusted by elite athletes [8].

Core Insights - Promino Nutritional Sciences Inc. announced that its flagship product, Rejuvenate Muscle Health™, was awarded "Best Drink 2025" at ECRM's Vitamin, Weight Management & Sports Nutrition Session, highlighting its competitive edge in the functional beverage market [1][8]. Product Performance - Rejuvenate Muscle Health™ was recognized as the Best-Tasting Drink in a taste test against over 30 brands, chosen by retail buyers from major grocery, pharmacy, and e-commerce retailers in the U.S. and Canada [3][5]. - The product is currently available in Raspberry Burst and Citrus Blast flavors, with additional flavors launching in Q1 2026 [4]. Market Presence - Rejuvenate Muscle Health™ is sold in over 8,000 retail locations across North America and has achieved Top 100 Protein Drink status on Amazon.com, with sales exceeding 4,000 units per month [4][5]. - The company plans to launch a Ready-to-Drink (RTD) version of Rejuvenate in Q3 2026, aiming to capture a larger share of the functional beverage market [7]. Strategic Positioning - The award validates the company's mission to provide clinically formulated products for muscle health, positioning Rejuvenate as a strong contender in the high-growth functional beverage space [8]. - The product's clean, sugar-free, dairy-free, and low-calorie formula is gaining traction, particularly among consumers using GLP-1 medications, where maintaining lean muscle is essential [6][9].

Core Viewpoint - Promino Nutritional Sciences Inc. has successfully revoked a Failure-to-File Cease Trade Order (FFCTO) issued by the Ontario Securities Commission, allowing for the resumption of trading of its securities in Canada [1][2]. Company Updates - The FFCTO was initially issued on May 7, 2025, due to the company's failure to file its annual audited financial statements and related documents for the fiscal year ended December 31, 2024 [2]. - The company submitted the required filings on September 12, 2025, with amendments made on November 19, 2025, which are available for review on SEDAR+ [2]. - Promino has applied to the Canadian Securities Exchange to reinstate trading of its common shares and has committed to holding an annual meeting of shareholders by February 26, 2026 [3]. Product Information - Promino is a Canadian nutraceutical company focused on developing science-based products for muscle health, with its lead product being Rejuvenate Muscle Health™, which has a new formulation aimed at enhancing muscle mass [4]. - The company also offers Promino™, a performance supplement designed for athletes to aid in muscle recovery and strength building [4].